Wedbush Starts Cleveland BioLabs (CBLI) at Outperform; Expect Gov't Supply Contract
Tweet Send to a Friend
Wedbush initiates coverage on Cleveland BioLabs (NASDAQ: CBLI) with a Outperform. PT $10.
Wedbush analyst says, "CBLI is developing CBLB502 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "CBLI is developing CBLB502 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
